We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.50 | 0.98% | 1,599.00 | 1,599.50 | 1,600.50 | 1,600.00 | 1,575.00 | 1,579.50 | 5,149,016 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.37 | 65.87B |
By Ian Walker
LONDON--GlaxoSmithKline PLC (GSK.LN) confirmed Thursday Philip Hampton will become chairman, replacing Christopher Gent on Sept. 1, 2015.
The pharmaceuticals giant said Mr. Hampton, currently chairman of Royal Bank of Scotland Group PLC (RBS.LN), will join the company on Jan. 1 as non-executive director, become deputy chairman on April 1, 2015 and then non-executive chairman on Sept. 1.
He will be paid 85,000 pounds ($138,890) a year as non-executive director, GBP350,000 when he becomes deputy chairman, and GBP700,000 on his appointment as chairman. His salary will be paid in cash and shares.
Separately, the 80% government-owned bank confirmed that Mr. Hampton will leave "after a suitable successor is appointed."
"Sir Philip has served as chairman since February 2009 and his departure will be in line with his longstanding intention to serve in the role for between five and seven years," the bank said.
-Write to Ian Walker at ian.walker@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions